Anti-RhD Antibody Therapy Modulates Human Natural Killer Cell Function

Mechanistically, scientists demonstrated that NK cell degranulation is mediated by binding of the Fc segment of anti-RhD antibodies to CD16, the main Fcγ receptor expressed on NK cells.